Papers

1

Total Citations

21

H-Index

1

About

C. Siragusa is a radiation oncologist whose research focuses on advancing stereotactic body radiotherapy (SBRT) for prostate cancer treatment. Their most cited work, a 2015 study on high-dose robotic SBRT, demonstrates how this technique can emulate high dose rate brachytherapy fractionation, offering a non-invasive alternative for localized prostate cancer patients. With 21 citations, this paper has contributed to the growing evidence base for SBRT as both monotherapy and pre-external-beam radiotherapy boost. Siragusa's research addresses critical questions in radiation oncology, particularly optimizing dose delivery to improve tumor control while minimizing toxicity. Their work sits at the intersection of technological innovation and clinical application, helping to establish SBRT as a viable treatment option that reduces treatment burden compared to traditional fractionation schedules. For students and researchers in radiation oncology, Siragusa's contributions highlight the ongoing evolution toward more precise, shorter-course radiotherapy regimens that maintain efficacy while improving patient quality of life.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer
21 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Azienda Ospedaliera Universitaria Policlinico "G. Martino"

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago